1letý cíl společnosti Horizon Discovery plc
Jaká je hodnota metriky 1letý cíl společnosti Horizon Discovery plc?
Hodnota metriky 1letý cíl společnosti Horizon Discovery Group plc je GBX22,657 +10,457.78%
Jaká je definice metriky 1letý cíl?
1-letý cíl (1-year target) je analytiky předpokládaná cena akcie za rok od dnešního dne.
One year target is an estimate of a stock price for a point in time equal to a year from the current date. The price level most often reflects the collective opinion of different analysts on where the stock will be trading a year from now. For an analyst to identify an individual estimate, they have to project what a company’s business will look like in a year, typically focusing on revenue and other significant factors. They also consider the willingness of investors to pay a certain price. While the average or median recommendation may be predictive and reflect the actual future value, the results are usually not extremely successful.
1letý cíl společností v sektoru Health Care sektor na LSE ve srovnání se společností Horizon Discovery plc
Čemu se věnuje společnost Horizon Discovery plc?
Horizon Discovery Group plc, a cell engineering company, engages in the design, manufacture, and application of gene editing and gene modulation tools in the United Kingdom, the United States, Europe, the Middle East, Africa, the Asia-Pacific, and internationally. The company operates through Screening, Research Reagents, Diagnostics, and BioProduction segments. It provides custom-made and off-the-shelf (OTS) RNAi gene modulation reagents, CRISPR reagents, synthetic SGRNAs, OTS cell models, and custom cell engineering services. The company also offers pooled CRISPR screens; arrayed RNAi and CRISPR screens, drug screens, and immunology assays; and RNAi and CRISPR screening libraries; and human T-Cell CRISPR screening service to meet the requirements of immunology based research in drug discovery. In addition, it provides OTS gene-edited CHO cells and custom CHO cell lines, and custom CHO gene engineering services; and OTS cell-based reference standards, made to order reference standards, and custom cell-based reference standards to evaluate molecular assays on a research use basis. The company serves customers in academic research labs, biopharmaceutical and diagnostics companies, and contract research and manufacturing organizations. It sells its products through direct field sales channel and e-commerce platform. The company has a partnership with the Rutgers, The State University of New Jersey to develop and commercialize base editing, a gene editing technology; strategic collaboration with Mammoth Biosciences to develop CRISPR tools to provide engineered cell lines for the biopharmaceutical industry; and collaboration with St George's University Hospital, London, and the European Molecular Genetics Quality Network to develop reference material for non-invasive prenatal testing. Horizon Discovery Group plc was founded in 2007 and is headquartered in Cambridge, the United Kingdom.
Firmy s metrikou 1letý cíl podobnou společnosti Horizon Discovery plc
- Hodnota metriky 1letý cíl společnosti MSG Networks je $225 +155,072.41%
- Hodnota metriky 1letý cíl společnosti Visa Inc je $225 -20.76%
- Hodnota metriky 1letý cíl společnosti VNET Inc je $33 +1,023.95%
- Hodnota metriky 1letý cíl společnosti TP ICAP plc je GBX22,540 +9,370.59%
- Hodnota metriky 1letý cíl společnosti Mishra Dhatu Nigam je ₨226 -43.05%
- Hodnota metriky 1letý cíl společnosti Redington (India) je ₨226 +17.41%
- Hodnota metriky 1letý cíl společnosti Horizon Discovery plc je GBX22,657 +10,457.78%
- Hodnota metriky 1letý cíl společnosti ECO Animal Health plc je GBX22,667 +20,553.30%
- Hodnota metriky 1letý cíl společnosti D. B. Corp je ₨227 -32.33%
- Hodnota metriky 1letý cíl společnosti On The Beach Plc je GBX22,710 +15,758.94%
- Hodnota metriky 1letý cíl společnosti Nordson je $227 -8.37%
- Hodnota metriky 1letý cíl společnosti Dollar General je $227 +182.18%
- Hodnota metriky 1letý cíl společnosti Jyothy Laboratories je ₨227 -60.05%